# Bupivacaine Effectiveness and Safety in SABER® Trial

> **NCT01052012** · PHASE3 · COMPLETED · sponsor: **Durect** · enrollment: 331 (actual)

## Conditions studied

- Postoperative Pain
- Abdominal Surgery

## Interventions

- **DRUG:** SABER-Bupivacaine
- **DRUG:** Bupivacaine HCl
- **DRUG:** SABER-Placebo

## Key facts

- **NCT ID:** NCT01052012
- **Lead sponsor:** Durect
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 331 (ACTUAL)
- **Last updated:** 2021-06-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052012, "Bupivacaine Effectiveness and Safety in SABER® Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01052012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*